FibroGen, Inc.
FGEN
$10.48
$0.131.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.07M | -10.01M | -47.58M | -121.79M | -168.32M |
| Total Depreciation and Amortization | 1.64M | 2.20M | 2.69M | 4.22M | 5.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.72M | 22.78M | 26.25M | 36.65M | 34.86M |
| Change in Net Operating Assets | -40.73M | -90.96M | -119.36M | -44.92M | -74.40M |
| Cash from Operations | -23.44M | -75.99M | -138.00M | -125.85M | -202.02M |
| Capital Expenditure | -252.00K | -253.00K | -266.00K | -376.00K | -978.00K |
| Sale of Property, Plant, and Equipment | 1.04M | 1.05M | 1.05M | 840.00K | 3.00K |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.66M | 73.91M | 125.21M | 134.05M | 188.95M |
| Cash from Investing | 2.45M | 74.70M | 125.99M | 134.51M | 187.98M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -22.00K | -33.00K | -40.00K | -90.00K | -96.00K |
| Issuance of Common Stock | 23.00K | 139.00K | 139.00K | 161.00K | 161.00K |
| Repurchase of Common Stock | -174.00K | -238.00K | -354.00K | -340.00K | -229.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.00K | -46.00K | -- | 0.00 | 0.00 |
| Cash from Financing | -219.00K | -178.00K | -255.00K | -506.00K | -401.00K |
| Foreign Exchange rate Adjustments | 338.00K | 1.94M | 751.00K | 1.94M | 2.57M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.87M | 466.00K | -11.51M | 10.09M | -11.87M |